Internal medicine journal
-
Internal medicine journal · Feb 2021
Meta AnalysisImmunosuppression as a risk factor for COVID-19: a meta-analysis.
While immunosuppression poses a theoretical increase in the risk of COVID-19, the nature of this relationship is yet to be ascertained. ⋯ Compared to the general population, immunosuppressed patients were not at significantly increased risk of COVID-19 infection. This finding provides support for current expert consensus statements, which have recommended the continuation of immunosuppressant therapy in the absence of COVID-19.